Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus

Jun Wang, Yibing Wu, Chunlong Ma, Giacomo Fiorin, Jizhou Wang, Lawrence H. Pinto, Robert A. Lamb, Michael L. Klein, William F. DeGrado

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

The influenza A virus M2 proton channel (A/M2) is the target of the antiviral drugs amantadine and rimantadine, whose use has been discontinued due to widespread drug resistance. Among the handful of drug-resistantmutants, S31N is found inmore than 95%of the currently circulating viruses and shows greatly decreased inhibition by amantadine. The discovery of inhibitors of S31N has been hampered by the limited size, polarity, and dynamic nature of its amantadine-binding site. Nevertheless, we have discovered smallmolecule drugs that inhibit S31N with potencies greater than amantadine's potency against WT M2. Drug binding locks the protein into a well-defined conformation, and the NMR structure of the complex shows the drug bound in the homotetrameric channel, threaded between the side chains of Asn31. Unrestrained molecular dynamics simulations predicted the same binding site. This S31N inhibitor, like other potent M2 inhibitors, contains a charged ammonium group. The ammonium binds as a hydrate to one of three sites aligned along the central cavity that appear to be hotspots for inhibition. These sites might stabilize hydronium-like species formed as protons diffuse through the outer channel to the proton-shuttling residue His37 near the cytoplasmic end of the channel.

Original languageEnglish (US)
Pages (from-to)1315-1320
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number4
DOIs
StatePublished - Jan 22 2013
Externally publishedYes

Fingerprint

Amantadine
Influenza A virus
Ion Channels
Protons
Ammonium Compounds
Pharmaceutical Preparations
Rimantadine
Binding Sites
Molecular Dynamics Simulation
Drug Resistance
Antiviral Agents
Carrier Proteins
Viruses

ASJC Scopus subject areas

  • General

Cite this

Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. / Wang, Jun; Wu, Yibing; Ma, Chunlong; Fiorin, Giacomo; Wang, Jizhou; Pinto, Lawrence H.; Lamb, Robert A.; Klein, Michael L.; DeGrado, William F.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 4, 22.01.2013, p. 1315-1320.

Research output: Contribution to journalArticle

Wang, Jun ; Wu, Yibing ; Ma, Chunlong ; Fiorin, Giacomo ; Wang, Jizhou ; Pinto, Lawrence H. ; Lamb, Robert A. ; Klein, Michael L. ; DeGrado, William F. / Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 4. pp. 1315-1320.
@article{d42b44e1f6c94d5296d2f3b018a8732e,
title = "Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus",
abstract = "The influenza A virus M2 proton channel (A/M2) is the target of the antiviral drugs amantadine and rimantadine, whose use has been discontinued due to widespread drug resistance. Among the handful of drug-resistantmutants, S31N is found inmore than 95{\%}of the currently circulating viruses and shows greatly decreased inhibition by amantadine. The discovery of inhibitors of S31N has been hampered by the limited size, polarity, and dynamic nature of its amantadine-binding site. Nevertheless, we have discovered smallmolecule drugs that inhibit S31N with potencies greater than amantadine's potency against WT M2. Drug binding locks the protein into a well-defined conformation, and the NMR structure of the complex shows the drug bound in the homotetrameric channel, threaded between the side chains of Asn31. Unrestrained molecular dynamics simulations predicted the same binding site. This S31N inhibitor, like other potent M2 inhibitors, contains a charged ammonium group. The ammonium binds as a hydrate to one of three sites aligned along the central cavity that appear to be hotspots for inhibition. These sites might stabilize hydronium-like species formed as protons diffuse through the outer channel to the proton-shuttling residue His37 near the cytoplasmic end of the channel.",
author = "Jun Wang and Yibing Wu and Chunlong Ma and Giacomo Fiorin and Jizhou Wang and Pinto, {Lawrence H.} and Lamb, {Robert A.} and Klein, {Michael L.} and DeGrado, {William F.}",
year = "2013",
month = "1",
day = "22",
doi = "10.1073/pnas.1216526110/-/DCSupplemental",
language = "English (US)",
volume = "110",
pages = "1315--1320",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus

AU - Wang, Jun

AU - Wu, Yibing

AU - Ma, Chunlong

AU - Fiorin, Giacomo

AU - Wang, Jizhou

AU - Pinto, Lawrence H.

AU - Lamb, Robert A.

AU - Klein, Michael L.

AU - DeGrado, William F.

PY - 2013/1/22

Y1 - 2013/1/22

N2 - The influenza A virus M2 proton channel (A/M2) is the target of the antiviral drugs amantadine and rimantadine, whose use has been discontinued due to widespread drug resistance. Among the handful of drug-resistantmutants, S31N is found inmore than 95%of the currently circulating viruses and shows greatly decreased inhibition by amantadine. The discovery of inhibitors of S31N has been hampered by the limited size, polarity, and dynamic nature of its amantadine-binding site. Nevertheless, we have discovered smallmolecule drugs that inhibit S31N with potencies greater than amantadine's potency against WT M2. Drug binding locks the protein into a well-defined conformation, and the NMR structure of the complex shows the drug bound in the homotetrameric channel, threaded between the side chains of Asn31. Unrestrained molecular dynamics simulations predicted the same binding site. This S31N inhibitor, like other potent M2 inhibitors, contains a charged ammonium group. The ammonium binds as a hydrate to one of three sites aligned along the central cavity that appear to be hotspots for inhibition. These sites might stabilize hydronium-like species formed as protons diffuse through the outer channel to the proton-shuttling residue His37 near the cytoplasmic end of the channel.

AB - The influenza A virus M2 proton channel (A/M2) is the target of the antiviral drugs amantadine and rimantadine, whose use has been discontinued due to widespread drug resistance. Among the handful of drug-resistantmutants, S31N is found inmore than 95%of the currently circulating viruses and shows greatly decreased inhibition by amantadine. The discovery of inhibitors of S31N has been hampered by the limited size, polarity, and dynamic nature of its amantadine-binding site. Nevertheless, we have discovered smallmolecule drugs that inhibit S31N with potencies greater than amantadine's potency against WT M2. Drug binding locks the protein into a well-defined conformation, and the NMR structure of the complex shows the drug bound in the homotetrameric channel, threaded between the side chains of Asn31. Unrestrained molecular dynamics simulations predicted the same binding site. This S31N inhibitor, like other potent M2 inhibitors, contains a charged ammonium group. The ammonium binds as a hydrate to one of three sites aligned along the central cavity that appear to be hotspots for inhibition. These sites might stabilize hydronium-like species formed as protons diffuse through the outer channel to the proton-shuttling residue His37 near the cytoplasmic end of the channel.

UR - http://www.scopus.com/inward/record.url?scp=84872875683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872875683&partnerID=8YFLogxK

U2 - 10.1073/pnas.1216526110/-/DCSupplemental

DO - 10.1073/pnas.1216526110/-/DCSupplemental

M3 - Article

C2 - 23302696

AN - SCOPUS:84872875683

VL - 110

SP - 1315

EP - 1320

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -